Mutation of protein kinase JAK2 in polycythemia vera: new perspectives in physiopathology and therapy

La Revue de médecine interne
I Marie, F Hervé

Abstract

The pathogenic mechanisms of polyvythemia vera (PV) still remain unknown, although there is evidence that genetic parameters may play a role in the pathogenesis of the disease. In 2005, many international research groups have identified an acquired mutation in the Janus kinase (JAK2) gene of chromosome 9; the mutation is defined by a valine-to-phenylalanine substitution at amino acid position 617 (V617F) in the JAK2's pseudokinase domain. JAK2 V617F mutation has been found in as high as 65 to 97% of patients with PV. Both in vitro and in vivo functional studies have further indicated that JAK2 V617F mutation leads to dysregulation of kinase activity, explaining, in part, clinical and biochemical features of PV. These data suggest that JAK2 V617F mutation may be a novel diagnostic marker of PV. Moreover, JAK2 V617F mutation finding may permit promising therapeutic approaches in patients with PV, particularly tyrosine kinase inhibitors; preliminary series have, in fact, underscored the potential efficacy of imatinib mesylate in PV.

References

Feb 11, 1991·The Journal of Clinical Investigation·C H DaiH S Gilbert
Jun 13, 1974·The New England Journal of Medicine·J F Prchal, A A Axelrad
Feb 1, 1997·Molecular and Cellular Biology·F KohlhuberI M Kerr
Feb 26, 1998·The New England Journal of Medicine·M SilvaJ L Fernández-Luna
Apr 25, 2000·Molecular and Cellular Biology·P SaharinenO Silvennoinen
Mar 8, 2002·Experimental Hematology·Robert KralovicsJosef T Prchal
Mar 18, 2003·The American Journal of the Medical Sciences·C Michael Jones, Tina Marie Dickinson
Mar 24, 2004·Leukemia Research·Geoffrey W Krystal
Apr 9, 2004·Blood·Jerry L Spivak, Richard T Silver
Apr 22, 2004·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·T U K DilekA Yildiz
Jun 11, 2004·Seminars in Hematology·Jerry L Spivak
Mar 10, 2005·Leukemia Research·Steven M FruchtmanUNKNOWN Anagrelide Study Group
Apr 29, 2005·The New England Journal of Medicine·John M Goldman
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
May 3, 2005·The Journal of Biological Chemistry·Runxiang ZhaoZhizhuang Joe Zhao
May 7, 2005·European Journal of Haematology·Björn AndreassonJan Westin
Oct 8, 2005·Seminars in Hematology·Ayalew Tefferi, Jerry L Spivak
Oct 22, 2005·The Journal of Biological Chemistry·Judith StaerkStefan N Constantinescu

❮ Previous
Next ❯

Citations

Apr 7, 2010·La Revue de médecine interne·J KonopackiJ-P Algayres

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.